Indies Pharma Jamaica Balance Sheet

Financials in millions JMD. Fiscal year is November - October.

Millions JMD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	429.98	421.7	221.97	256.68	234.63	187.74
Cash & Short-Term Investments	429.98	421.7	221.97	256.68	234.63	187.74
Cash Growth	56.25%	89.98%	-13.52%	9.40%	24.98%	-40.14%
Accounts Receivable	160.64	135.52	168.1	156.69	106.83	118.53
Other Receivables	129.48	6.48	28.57	2.96	3.46	7.42
Receivables	290.12	142	196.67	159.65	110.29	125.94
Inventory	142.17	156.12	248.58	170.38	175.51	222.6
Prepaid Expenses	-	135.11	65.04	110.65	57.61	36.31
Other Current Assets	122.34	109.7	59.74	26.33	41.02	0.76
Total Current Assets	984.6	964.62	792	723.7	619.06	573.35
Property, Plant & Equipment	1,522	1,335	915.81	968.36	949.4	979.87
Long-Term Investments	17.22	17.22	16.36	16.3	79.44	146.75
Other Intangible Assets	525.1	494.69	461.71	441.75	379.31	317.63
Long-Term Deferred Tax Assets	5.55	5.55	2.2	2.2	-	-
Other Long-Term Assets	94.81	238.26	119.12	87.87	21.01	18.94
Total Assets	3,149	3,055	2,307	2,240	2,048	2,037
Accounts Payable	97.07	117.14	41.64	35.64	16.31	34.87
Accrued Expenses	4.15	-	-	-	-	-
Short-Term Debt	11.79	8.09	6.64	11.99	7.86	3.44
Current Portion of Long-Term Debt	-	-	805	-	-	-
Current Portion of Leases	34.58	6.42	43.35	34.19	1.22	46.58
Current Income Taxes Payable	9.2	2.43	24.18	15.74	-	-
Other Current Liabilities	81.65	59.67	13.27	45.27	35.08	13.32
Total Current Liabilities	238.44	193.75	934.08	142.84	60.48	98.2
Long-Term Debt	1,000	1,000	-	805	805	805
Long-Term Leases	158.86	-	-	50.92	1.25	-
Other Long-Term Liabilities	-	131.39	79.47	22.39	24.54	46.6
Total Liabilities	1,397	1,325	1,014	1,021	891.27	949.8
Common Stock	244.58	244.58	244.58	244.58	244.58	244.58
Retained Earnings	613.74	591.97	590.58	515.98	453.9	383.69
Comprehensive Income & Other	893.48	893.48	458.48	458.48	458.48	458.48
Shareholders' Equity	1,752	1,730	1,294	1,219	1,157	1,087
Total Liabilities & Equity	3,149	3,055	2,307	2,240	2,048	2,037
Total Debt	1,205	1,015	854.99	902.1	815.33	855.02
Net Cash (Debt)	-775.25	-592.81	-633.02	-645.42	-580.7	-667.27
Net Cash Per Share	-0.58	-0.44	-0.48	-0.48	-0.44	-0.50
Filing Date Shares Outstanding	1,333	1,333	1,333	1,333	1,333	1,333
Total Common Shares Outstanding	1,333	1,333	1,333	1,333	1,333	1,333
Working Capital	746.16	770.87	-142.08	580.87	558.59	475.15
Book Value Per Share	1.31	1.30	0.97	0.91	0.87	0.82
Tangible Book Value	1,227	1,235	831.93	777.3	777.65	769.12
Tangible Book Value Per Share	0.92	0.93	0.62	0.58	0.58	0.58
Land	-	1,200	765	765.7	792.7	792.7
Machinery	-	153.54	118.05	115.29	118.53	100.42
Leasehold Improvements	-	111.95	107.92	103.79	146.79	138.54

Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.